left-arrow right-arrow pinterest facebook google_plus linkedin

Skin Cancer Trials

The following listings are our current trials. If you have questions or want to learn more about the trial, please contact us and provide the Methodist Health System Trial Code listed with the description.


ECOG-ACRIN EA6134

Status: Recruiting | Phase III

Original Title: Testing Therapy Sequence for Advanced BRAF Mutation Melanoma

Study Purpose: The purpose of this study to compare the good and bad effects of the sequence of immunotherapy followed by BRAF inhibitor therapy if and when it gets worse. Learn more


ECOG-ACRIN EA6174

Status: Recruiting | Phase III

Official Title: Testing Pembrolizumab versus Observation in Patients with Merkel Cell Carcinoma after Surgery

Study Purpose: This study is being done to see if the chance of cancer growing back can be lowered by adding the study drug, pembrolizumab, after surgery. Learn more.


SWOG S1616

Status: Recruiting | Phase II

Official Title: Testing treatment with Ipilimumab and Nivolumab compared to treatment with Ipilimumab alone in advanced melanoma.  

Study Purpose: The purpose of this study is to compare any good and bad effects of using Ipilimumab in combination with Nivolumab to the usual approach of treating with Ipilimumab alone. Learn more